L-Asparaginase Inj
Description
Indications
Engenase is L-asparaginase inj. While observing the qualitative difference between normal cells and those from childhood lymphoblastic leukemia, the leukemia cells are deficient in L-asparagine synthetase and depend on the supply of L-asparagine from the medium (Blood). The enzyme L-asparaginase (from E. coil) degrades L-asparagine to L-aspartic acid, depriving leukemic cells of an essential metabolite and ultimately may lead to cell death."


It is indicated for the treatment of
  • Acute Lymphoblastic Leukemia
Product variants & features
 Product  Strength  Features
 Presentation
ENGENASE  10000IU     10ml vial  
 
 

Claris Lifesciences Ltd. All Rights Reserved.  :: Terms of Use  ::Privacy Policy ::Sitemap